BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8738395)

  • 21. Nm23/nucleoside diphosphate (NDP) kinase expression in human malignant melanomas: significance and implications in tumor biology.
    Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
    Anticancer Res; 1997; 17(1A):505-11. PubMed ID: 9066703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical analysis of nm23 gene product/NDP kinase expression in pulmonary adenocarcinoma: lack of prognostic value.
    Higashiyama M; Doi O; Yokouchi H; Kodama K; Nakamori S; Tateishi R; Kimura N
    Br J Cancer; 1992 Sep; 66(3):533-6. PubMed ID: 1325827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of nm23-H1 and nm23-H2 proteins in prostate carcinoma.
    Konishi N; Nakaoka S; Tsuzuki T; Matsumoto K; Kitahori Y; Hiasa Y; Urano T; Shiku H
    Jpn J Cancer Res; 1993 Oct; 84(10):1050-4. PubMed ID: 7693635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The NM23 gene and its expression in oral squamous cell carcinoma.
    Lo Muzio L; Mignogna MD; Pannone G; Staibano S; Procaccini M; Serpico R; De Rosa G; Scully C
    Oncol Rep; 1999; 6(4):747-51. PubMed ID: 10373649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis.
    Viel A; Dall'Agnese L; Canzonieri V; Sopracordevole F; Capozzi E; Carbone A; Visentin MC; Boiocchi M
    Cancer Res; 1995 Jun; 55(12):2645-50. PubMed ID: 7780979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association between nm23 gene expression and survival in patients with sarcomas.
    Royds JA; Robinson MH; Stephenson TJ; Rees RC; Fisher C
    Br J Cancer; 1997; 75(8):1195-200. PubMed ID: 9099969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variability of nm23-H1/NDPK-A expression in human lymphomas and its relation to tumour aggressiveness.
    Aryee DN; Simonitsch I; Mosberger I; Kos K; Mann G; Schlögl E; Pötschger U; Gadner H; Radaszkiewicz T; Kovar H
    Br J Cancer; 1996 Dec; 74(11):1693-8. PubMed ID: 8956779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nm23/NDP kinase and cancer metastasis].
    Kimura N
    Gan To Kagaku Ryoho; 1993 Feb; 20(3):332-7. PubMed ID: 8382464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nucleoside diphosphate kinase/NM23 expression in breast cancer: lack of correlation with lymph-node metastasis.
    Sastre-Garau X; Lacombe ML; Jouve M; Véron M; Magdelénat H
    Int J Cancer; 1992 Feb; 50(4):533-8. PubMed ID: 1537618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma.
    Zafon C; Obiols G; Castellví J; Tallada N; Galofré P; Gemar E; Mesa J; Simó R
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3975-80. PubMed ID: 11502841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NM23-H1 immunostaining is inversely associated with tumour staging but not overall survival or disease recurrence in colorectal carcinomas.
    Cheah PY; Cao X; Eu KW; Seow-Choen F
    Br J Cancer; 1998 Apr; 77(7):1164-8. PubMed ID: 9569056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and mutational analysis of Nm23-H1 in liver metastases of colorectal cancer.
    Heide I; Thiede C; Poppe K; de Kant E; Huhn D; Rochlitz C
    Br J Cancer; 1994 Dec; 70(6):1267-71. PubMed ID: 7981087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of nm23 in gastric carcinoma: association with tumor progression and poor prognosis.
    Müller W; Schneiders A; Hommel G; Gabbert HE
    Cancer; 1998 Dec; 83(12):2481-7. PubMed ID: 9874452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical analysis of nm23/NDP kinase expression in human lung adenocarcinoma: association with tumor progression in Clara cell type.
    Ozeki Y; Takishima K; Mamiya G
    Jpn J Cancer Res; 1994 Aug; 85(8):840-6. PubMed ID: 7928630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53.
    Ambros RA; Vigna PA; Figge J; Kallakury BV; Mastrangelo A; Eastman AY; Malfetano J; Figge HL; Ross JS
    Cancer; 1994 Mar; 73(6):1686-92. PubMed ID: 8156496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of nm23-H1 in prostatic intraepithelial neoplasia and adenocarcinoma.
    Myers RB; Srivastava S; Oelschlager DK; Brown D; Grizzle WE
    Hum Pathol; 1996 Oct; 27(10):1021-4. PubMed ID: 8892585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Low expression of nm23-H1 mRNA and its protein in breast cancer].
    Guo W; Wang Y; Zhuang X; Bai Y; Zhang J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):91-3. PubMed ID: 10751528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of nm23-H1 in transitional cell carcinoma of the upper urinary tract.
    Cheng HL; Tong YC; Tzai TS; Weng CL; Ho CL; Yang WH; Lin JS; Chow NH
    Oncol Rep; 2001; 8(1):193-6. PubMed ID: 11115597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of NDP kinase nm23 associated with ploidy image analysis in colorectal cancer.
    Giarnieri E; Alderisio M; Valli C; Vecchione A; Forte A; Turano R; Pulcini M
    Anticancer Res; 1995; 15(5B):2049-53. PubMed ID: 8572601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical analysis of nm23-H1 protein in bladder cancer.
    Kuo JY; Chiang H; Chen KK; Chang LS
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jul; 62(7):411-7. PubMed ID: 10418173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.